ReviewFrontiers in bioengineering and biotechnology2026
Bioceramic bone tissue-engineered substitutes with anti-inflammatory effects in periodontitis.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis is a chronic inflammatory oral disease characterized by irreversible alveolar bone resorption, which severely impairs oral health and even leads to tooth loss. Clinical bone augmentation therapy for alveolar bone defects mainly relies on exogenous bone substitute materials. However, traditional materials are prone to implantation failure due to the persistent inflammatory microenvironment and bacterial infection in the periodontal area. The addition of antibiotics to improve antibacterial properties not only induces bacterial resistance but also causes systemic toxic and side effects, making it difficult to meet clinical treatment needs. This review focuses on the core demand for bone substitute materials in periodontitis treatment to simultaneously achieve antibacterial, anti-inflammatory, and osteogenic functions-an essential characteristic that distinguishes such materials from conventional antibacterial drugs and single-function bone graft materials. We systematically elaborate on multiple interrelated inflammatory signaling pathways (e.g., RANKL/RANK/OPG, cGAS-STING, NF-κB, JAK-STAT, MAPK, PI3K/AKT, HIF-1, TGF-β/SMAD, Wnt/β-catenin, Hippo) and inflammasome mechanisms involved in periodontitis-associated alveolar bone resorption, exploring potential targets for screening excellent anti-inflammatory and osteogenic active molecules. On this basis, we summarize modification strategies for bioceramic bone tissue-engineered substitutes, including incorporating metal ions (Ag, Cu, Sr, Mn, Mg, Zn, etc.) and natural anti-inflammatory molecules into the material matrix to enhance their multifunctional properties while maintaining favorable physical and biological characteristics. We also discuss structural and functional optimization of composites via surface morphology modification, photothermal, and photodynamic coating construction to improve adaptability to the periodontal inflammatory microenvironment. These reconstructed multifunctional composite bioceramic materials integrate antibacterial, anti-inflammatory, and osteogenic functions, eliminating periodontal bacterial infection, alleviating local chronic inflammation, and actively promoting osteoblast differentiation and alveolar bone defect repair, thereby perfectly matching the pathological characteristics of periodontitis. This review clarifies the core design concept of multifunctional integration for bioceramic bone tissue-engineered substitutes in periodontitis treatment and provides a theoretical basis and technical reference for developing novel bone graft materials with clinical transformation potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.